Published in Br J Clin Pharmacol on November 05, 2008
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ (2011) 2.32
Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS One (2012) 1.74
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev (2013) 1.59
Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf (2010) 1.56
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies. Eur J Clin Pharmacol (2011) 1.46
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med (2014) 1.31
Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol (2013) 1.20
Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis. PLoS One (2010) 1.05
The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One (2013) 0.96
Statins and the risk of lung cancer: a meta-analysis. PLoS One (2013) 0.92
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders. Pharmacol Res (2011) 0.89
Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget (2015) 0.88
Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort. Mol Med (2009) 0.87
Effect of pravastatin and fosinopril on recurrent urinary tract infections. J Antimicrob Chemother (2012) 0.87
Statins, cognition, and dementia—systematic review and methodological commentary. Nat Rev Neurol (2015) 0.85
Pharmacoepidemiology. Br J Clin Pharmacol (2012) 0.85
Statins for age-related macular degeneration. Cochrane Database Syst Rev (2009) 0.84
Statins for age-related macular degeneration. Cochrane Database Syst Rev (2012) 0.84
Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int (2016) 0.82
Protopathic bias in observational studies on statin effectiveness. Eur J Clin Pharmacol (2009) 0.82
Improving vascular health: are pills the answer? BMJ (2012) 0.82
From medical records to clinical science. Perm J (2012) 0.82
Statins for age-related macular degeneration. Cochrane Database Syst Rev (2015) 0.81
Dynamics of long-term statin therapy. Eur J Clin Pharmacol (2011) 0.81
Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia. Eur J Epidemiol (2014) 0.80
The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients. J Clin Diagn Res (2015) 0.79
The effect of statin therapy on the incidence of infections: a retrospective cohort analysis. Am J Med Sci (2014) 0.79
Statins for age-related macular degeneration. Cochrane Database Syst Rev (2016) 0.78
Statins and Breast Cancer: Future Directions in Chemoprevention. Curr Breast Cancer Rep (2013) 0.78
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatr (2011) 0.78
Statins, mood, sleep, and physical function: a systematic review. Eur J Clin Pharmacol (2014) 0.77
LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies. Sci Rep (2016) 0.77
Statin use and markers of immunity in the Doetinchem cohort study. PLoS One (2013) 0.76
Cholesterol, statins, and dementia: what the cardiologist should know. Clin Cardiol (2015) 0.76
Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Thromb Res (2015) 0.76
Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts. BMJ Open (2017) 0.75
Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study. Osteoporos Int (2015) 0.75
Statin use and risk of fracture: a meta-analysis. Int J Clin Exp Med (2015) 0.75
The association between statin use and risk of age-related macular degeneration. Sci Rep (2015) 0.75
Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study. J Gerontol A Biol Sci Med Sci (2016) 0.75
The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis. BMC Pharmacol Toxicol (2013) 0.75
Statin use and osteoarthritis. The authors’ reply. J Gen Intern Med (2013) 0.75
Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups. Br J Gen Pract (2017) 0.75
Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort. Sci Rep (2017) 0.75
The Use of Statins and Risk of Community-Acquired Pneumonia. Curr Infect Dis Rep (2017) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med (2007) 7.96
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Statins and the risk of colorectal cancer. N Engl J Med (2005) 6.86
Validity of the general practice research database. Pharmacotherapy (2003) 6.78
Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet (2004) 6.24
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Statins and the risk of dementia. Lancet (2000) 5.65
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol (2007) 4.93
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
The safety of statins in clinical practice. Lancet (2007) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol (2006) 3.36
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
Statins: panacea for sepsis? Lancet Infect Dis (2006) 2.32
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol (2002) 2.18
Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer (2007) 2.00
Risk of macular degeneration in users of statins: cross sectional study. BMJ (2001) 1.92
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry (2005) 1.78
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72
Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (2002) 1.65
Vascular cognitive impairment. Nat Clin Pract Neurol (2006) 1.64
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol (2005) 1.55
Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf (2007) 1.50
Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy? Arthritis Rheum (2006) 1.48
Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis (2006) 1.44
Should we lower cholesterol as much as possible? BMJ (2006) 1.43
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation (2002) 1.34
Statin use and incident nuclear cataract. JAMA (2006) 1.29
Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol (2007) 1.21
A case control study of age related macular degeneration and use of statins. Br J Ophthalmol (2005) 1.15
Statins for the treatment of multiple sclerosis: cautious hope. Lancet (2004) 1.09
Statins and fracture risk. A systematic review. Pharmacoepidemiol Drug Saf (2007) 1.02
Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf (2006) 1.02
Cataract and the use of statins: a case-control study. QJM (2003) 0.94
Statins: novel additions to the dermatologic arsenal? Exp Dermatol (2004) 0.90
The lesser known effects of statins: benefits on infectious outcomes may be explained by "healthy user" effect. BMJ (2006) 0.87
Alopecia associated with atorvastatin. Am J Med (2002) 0.82
Lovastatin-induced hemolytic anemia: not a class-specific reaction. Am J Med (1995) 0.81
Thrombotic thrombocytopenic purpura associated with statin treatment. Postgrad Med J (2004) 0.79
Disorder resembling Guillain-Barré syndrome on initiation of statin therapy. Muscle Nerve (2004) 0.78
Commentary: Matched cohorts can be useful. BMJ (2003) 0.78
Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol (2010) 10.70
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
What errors do peer reviewers detect, and does training improve their ability to detect them? J R Soc Med (2008) 4.92
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax (2012) 4.40
Effects of training on quality of peer review: randomised controlled trial. BMJ (2004) 4.20
Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ (2002) 3.84
Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ (2005) 3.09
Measles eradication: past is prologue. Lancet (2010) 3.00
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet (2006) 2.94
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet. Lancet (2008) 2.76
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis (2003) 2.75
Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol (2002) 2.45
Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet (2002) 2.34
There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: Lack of support for the hygiene hypothesis. J Allergy Clin Immunol (2003) 2.34
Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ (2011) 2.32
Validation of the diagnosis of autism in general practitioner records. BMC Public Health (2004) 2.22
The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med (2002) 2.22
Eliciting and using expert opinions about dropout bias in randomized controlled trials. Clin Trials (2007) 2.15
Body mass index and obstructive sleep apnoea in the UK: a cross-sectional study of the over-50s. Prim Care Respir J (2012) 2.11
Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ (2005) 2.04
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ (2004) 2.03
MMR vaccination and pervasive developmental disorders: a case-control study. Lancet (2004) 2.02
Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum (2007) 1.98
Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ Health Perspect (2004) 1.97
Intra-rater and inter-rater reliability of a weight-bearing lunge measure of ankle dorsiflexion. Aust J Physiother (1998) 1.96
Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology (2003) 1.83
Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest (2013) 1.79
A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis (2004) 1.77
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med (2008) 1.65
Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology (2003) 1.63
An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting. Int J Epidemiol (2005) 1.58
Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open (2013) 1.57
Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Perspect (2003) 1.53
The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making (2010) 1.51
Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age. Int J Epidemiol (2006) 1.46
Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ (2004) 1.45
The effect of scientific misconduct on the results of clinical trials: a Delphi survey. Contemp Clin Trials (2005) 1.45
Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology (2006) 1.45
Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2005) 1.45
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer (2007) 1.44
Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med (2003) 1.42
Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42
The Prevalence of Huntington's Disease. Neuroepidemiology (2016) 1.40
Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction (2007) 1.40
JCVI processes are at least as robust as those of scientific journals. BMJ (2012) 1.38
Extra scrutiny for industry funded trials. BMJ (2005) 1.38
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
Liver cancer in low and middle income countries. BMJ (2003) 1.33
The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa. J Gastroenterol Hepatol (2002) 1.32
Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry (2013) 1.30
A quantitative proteomic analysis of biofilm adaptation by the periodontal pathogen Tannerella forsythia. Proteomics (2010) 1.29
Risk factors for neonatal morbidity and mortality among "healthy," late preterm newborns. Semin Perinatol (2006) 1.29
The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med (2007) 1.26
Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol (2007) 1.25
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain (2004) 1.24
Validation of THIN data for non-melanoma skin cancer. Qual Prim Care (2008) 1.24
Trends in bronchiectasis mortality in England and Wales. Respir Med (2010) 1.24
Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol (2009) 1.23
Early discharge among late preterm and term newborns and risk of neonatal morbidity. Semin Perinatol (2006) 1.23
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood (2002) 1.19
The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer (2009) 1.18
Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf (2011) 1.16
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One (2008) 1.16
Doubts over head injury studies. BMJ (2007) 1.15
Monitoring of long-term toxicities of HIV treatments: an international perspective. AIDS (2003) 1.14
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev (2005) 1.12
Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program. BMC Infect Dis (2014) 1.11
Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink. BMC Cardiovasc Disord (2014) 1.10
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One (2013) 1.10
Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ (2003) 1.08
Identifying the clinical characteristics of older people living in care homes using a novel approach in a primary care database. Age Ageing (2010) 1.08
Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant (2006) 1.07
EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia. Trop Med Int Health (2004) 1.04
Case-control study of mosquito nets against malaria in the Amazon region of Colombia. Am J Trop Med Hyg (2005) 1.03
Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia (2005) 1.03
Vaccination and allergic disease: a birth cohort study. Am J Public Health (2004) 1.02
Juvenile Huntington's disease: a population-based study using the General Practice Research Database. BMJ Open (2013) 1.02
Evaluation of data quality at the Gambia national cancer registry. Int J Cancer (2012) 1.02
Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage? Trop Med Int Health (2005) 1.02
Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. PLoS One (2009) 1.01
Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study. BMC Pulm Med (2013) 1.01
Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol (2008) 1.01
Racial and geographic factors in the incidence of Legg-Calvé-Perthes' disease: a systematic review. Am J Epidemiol (2012) 1.01
Last observation carry-forward and last observation analysis. Stat Med (2004) 1.00
Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression. J Gastroenterol Hepatol (2005) 1.00
Risk of falls associated with antihypertensive medication: population-based case-control study. Age Ageing (2010) 1.00
Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One (2013) 1.00
Early life risk factors for atopic dermatitis in Ethiopian children. J Allergy Clin Immunol (2005) 1.00
Mode of delivery and risk of developing allergic disease. J Allergy Clin Immunol (2002) 0.97
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
Lessons learned from a multiple-dose post-operative analgesic trial. Pain (2004) 0.97
The epidemiology of delirium: challenges and opportunities for population studies. Am J Geriatr Psychiatry (2013) 0.96